PACLITAXEL for Thyroid cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 54 adverse event reports in the FDA FAERS database where PACLITAXEL was used for Thyroid cancer.
Most Reported Side Effects for PACLITAXEL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Neutropenia | 4,553 | 5.9% | 572 | 1,391 |
| Nausea | 4,521 | 5.9% | 488 | 2,147 |
| Dyspnoea | 4,519 | 5.8% | 453 | 2,052 |
| Diarrhoea | 4,289 | 5.6% | 591 | 2,513 |
| Off label use | 4,075 | 5.3% | 595 | 1,415 |
| Anaemia | 3,949 | 5.1% | 599 | 1,918 |
| Neuropathy peripheral | 3,508 | 4.5% | 404 | 788 |
| Malignant neoplasm progression | 3,484 | 4.5% | 916 | 760 |
| Fatigue | 3,418 | 4.4% | 500 | 1,568 |
| Death | 3,143 | 4.1% | 3,137 | 378 |
| Pyrexia | 3,083 | 4.0% | 352 | 2,331 |
| Vomiting | 3,049 | 3.9% | 371 | 1,785 |
| Disease progression | 2,939 | 3.8% | 801 | 554 |
| Febrile neutropenia | 2,938 | 3.8% | 569 | 1,915 |
| Thrombocytopenia | 2,580 | 3.3% | 424 | 939 |
Other Indications for PACLITAXEL
Breast cancer (10,215)
Product used for unknown indication (6,156)
Ovarian cancer (4,631)
Non-small cell lung cancer (4,609)
Triple negative breast cancer (3,863)
Pancreatic carcinoma (3,386)
Breast cancer metastatic (3,241)
Pancreatic carcinoma metastatic (2,712)
Lung neoplasm malignant (1,747)
Chemotherapy (1,425)
Other Drugs Used for Thyroid cancer
LENVATINIB (2,668)
CABOZANTINIB S-MALATE (1,615)
VANDETANIB (591)
DABRAFENIB (583)
TRAMETINIB DIMETHYL SULFOXIDE (482)
SORAFENIB (399)
LEVOTHYROXINE (299)
PAZOPANIB (264)
PRALSETINIB (199)
CABOZANTINIB (125)